01 25Gowling WLG (Canada) LLP
01 41341152
02 42201781
03 52443294
04 32474943
05 52523577
06 22549467
07 22708627
01 10TOCILIZUMAB
02 15Tocilizumab
01 10SOLUTION
02 15solution
01 42015-06-07
02 42017-12-12
03 52022-04-02
04 32023-02-14
05 52024-04-28
06 22024-12-17
07 22028-12-26
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
Brand Name : ACTEMRA
Patent Number : 2443294
Filing Date : 2002-04-02
Strength per Unit : 80 mg / 4 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
Patent Expiration Date : 2017-12-12
Date Granted : 2000-12-12
Brand Name : ACTEMRA
Patent Number : 1341152
Filing Date : 1989-01-19
Strength per Unit : 80 mg / 4 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-12-12
Date Granted : 2000-12-12
Patent Expiration Date : 2015-06-07
Date Granted : 2010-01-12
Brand Name : ACTEMRA
Patent Number : 2201781
Filing Date : 1995-06-07
Strength per Unit : 80 mg / 4 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-06-07
Date Granted : 2010-01-12
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
Brand Name : ACTEMRA
Patent Number : 2443294
Filing Date : 2002-04-02
Strength per Unit : 200 mg / 10 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
Patent Expiration Date : 2015-06-07
Date Granted : 2010-01-12
Brand Name : ACTEMRA
Patent Number : 2201781
Filing Date : 1995-06-07
Strength per Unit : 200 mg / 10 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-06-07
Date Granted : 2010-01-12
Patent Expiration Date : 2017-12-12
Date Granted : 2000-12-12
Brand Name : ACTEMRA
Patent Number : 1341152
Filing Date : 1989-01-19
Strength per Unit : 200 mg / 10 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-12-12
Date Granted : 2000-12-12
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
Brand Name : ACTEMRA
Patent Number : 2443294
Filing Date : 2002-04-02
Strength per Unit : 400 mg / 20 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
Patent Expiration Date : 2017-12-12
Date Granted : 2000-12-12
Brand Name : ACTEMRA
Patent Number : 1341152
Filing Date : 1989-01-19
Strength per Unit : 400 mg / 20 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2017-12-12
Date Granted : 2000-12-12
Patent Expiration Date : 2015-06-07
Date Granted : 2010-01-12
Brand Name : ACTEMRA
Patent Number : 2201781
Filing Date : 1995-06-07
Strength per Unit : 400 mg / 20 mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-06-07
Date Granted : 2010-01-12
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
Brand Name : ACTEMRA
Patent Number : 2443294
Filing Date : 2002-04-02
Strength per Unit : 162 mg / 0.9mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2022-04-02
Date Granted : 2013-09-24
